An interventional study of Test-and-treat EHR-CHW intervention and Usual care of EHR-only intervention in H. Pylori Infection, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2024-07-03.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Supportive care
This study will assess the efficacy, adoption, and impact of an integrated intervention to improve adherence to recommended stomach cancer prevention guidelines (H. pylori test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted theory-based intervention involves: 1) a health systems-level intervention using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies; and 2) a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability. Using a 2-arm randomized controlled trial (RCT) design, > 144 Chinese American patients across NYC safety net hospital endoscopy clinics and primary health centers will participate.
NYU Langone Health is the lead sponsor of 1,421 studies on the registry; 254 are open to participants now.
Of its 231 completed or terminated interventional studies of FDA-regulated products, 195 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies;
Other: Test-and-treat EHR-CHW intervention
a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability
Other: Usual care of EHR-only intervention
a health systems-level intervention using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies
a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability.
Number of Participants With Eradication of H. Pylori (ITT)
Measured using breath ammonia measurement, fecal stool antigen test or other clinically approved H. pylori infection diagnostic test. Data extracted from patient EHR. Includes positive results for those with self-reported or missing results.
Time frame: Up to Month 3-Post Treatment
Number of Participants With Eradication of H. Pylori (Clinically Confirmed)
Measured using breath ammonia measurement, fecal stool antigen test or other clinically approved H. pylori infection diagnostic test. Data extracted from patient EHR.
Time frame: Up to Month 3-Post Treatment
Change in Ottawa Decision Self-Efficacy Scale Score From Baseline to 6 Months
Participants completed the Ottawa Decision Self-Efficacy Scale, which assessed participants' confidence in making an informed choice, at baseline and 6-month follow-up. The scale consists of 11 questions on a 5-point Likert scale from 0 (not at all confident) to 4 (very confident). The raw score is the sum of responses. The raw score is converted to a standardized total score that ranges from 0 to 100; higher total scores indicate greater decision self-efficacy.
Time frame: Baseline, Month 6
Change in Medication Adherence Report Scale (MARS-5) Score From Baseline to Month 6
Participants completed the MARS-5 self-assessment of medication adherence at baseline and 6-month follow-up. One item assessed unintentional non-adherence, while four items assessed intentional non-adherence. Participants indicated how often each statement applied to them in the past month on a 5-point Likert scale (1=always, 2=often, 3=sometimes, 4=rarely, 5=never), resulting in a total score ranging from 5 to 25. Adherence is defined as a score of 25.
Time frame: Baseline, Month 6
Change in Stomach Cancer Knowledge Between Baseline and 6-months
Participants were asked about associations with the risk of getting stomach cancer (alcohol, spicy food, stress, family history, h. pylori infection, smoking, salty food, being physically inactive, pickled food, food high in sugar). True or false was chosen. Variables were recoded to correct (1) and incorrect (0), and summed for a final score (0-10, 10=highest knowledge)
Time frame: Baseline, Month 6
Change in H. Pylori Knowledge Between Baseline and 6-months
Participants were asked about associations with h. pylori (blood, untreated/contaminated water, rats, mosquitoes, contaminated food, vomit, poor sanitation). True or false was chosen. Variables were recoded to correct (1) and incorrect (0), and summed for a final score (0-7, 7=highest knowledge)
Time frame: Baseline, Month 6
Change in PROMIS Global Physical Health T-Score Between Baseline and 6-months
Participants completed the PROMIS Global Physical Health Scale, which assessed participants' physical health, at baseline and 6-month follow-up. Four questions assessed global physical health. Three questions were administered using five-category response scales, and one item used a response scale of 0-10 that was recoded to five categories. Responses are recoded into t-scores, which rescales the raw sum score into a standardized score from 0-100, with a mean of 50 and a standard deviation of 10. Higher scores indicate more of the concept being measured.
Time frame: Baseline, Month 6
Change in PROMIS Global Mental Health T-Score Between Baseline and 6-months
Participants completed the PROMIS Global Mental Health Scale, which assessed participants' mental health, at baseline and 6-month follow-up. Four questions assessed global mental health, and all were administered using five-category response scales. Responses are recoded into t-scores, which rescales the raw sum score into a standardized score from 0-100, with a mean of 50 and a standard deviation of 10. Higher scores indicate more of the concept being measured.
Time frame: Baseline, Month 6
| Milestone | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Started | 67 | 68 |
| Completed | 67 | 64 |
| Not completed | 0 | 4 |
| Withdrew: Lost to follow-up | 0 | 4 |
Measured using breath ammonia measurement, fecal stool antigen test or other clinically approved H. pylori infection diagnostic test. Data extracted from patient EHR. Includes positive results for those with self-reported or missing results.
| Participants | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Number of Participants With Eradication of H. Pylori (ITT) | 49 | 54 |
Measured using breath ammonia measurement, fecal stool antigen test or other clinically approved H. pylori infection diagnostic test. Data extracted from patient EHR.
| Participants | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Number of Participants With Eradication of H. Pylori (Clinically Confirmed) | 49 | 54 |
Participants completed the Ottawa Decision Self-Efficacy Scale, which assessed participants' confidence in making an informed choice, at baseline and 6-month follow-up. The scale consists of 11 questions on a 5-point Likert scale from 0 (not at all confident) to 4 (very confident). The raw score is the sum of responses. The raw score is converted to a standardized total score that ranges from 0 to 100; higher total scores indicate greater decision self-efficacy.
| score on a scale | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Change in Ottawa Decision Self-Efficacy Scale Score From Baseline to 6 Months | 5 ± 13.59 | 5.7 ± 11.77 |
Participants completed the MARS-5 self-assessment of medication adherence at baseline and 6-month follow-up. One item assessed unintentional non-adherence, while four items assessed intentional non-adherence. Participants indicated how often each statement applied to them in the past month on a 5-point Likert scale (1=always, 2=often, 3=sometimes, 4=rarely, 5=never), resulting in a total score ranging from 5 to 25. Adherence is defined as a score of 25.
| score on a scale | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Change in Medication Adherence Report Scale (MARS-5) Score From Baseline to Month 6 | 0.58 ± 2.69 | 0.77 ± 2.95 |
Participants were asked about associations with the risk of getting stomach cancer (alcohol, spicy food, stress, family history, h. pylori infection, smoking, salty food, being physically inactive, pickled food, food high in sugar). True or false was chosen. Variables were recoded to correct (1) and incorrect (0), and summed for a final score (0-10, 10=highest knowledge)
| score on a scale | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Change in Stomach Cancer Knowledge Between Baseline and 6-months | 1.58 ± 2.25 | 3.25 ± 2.9 |
Participants were asked about associations with h. pylori (blood, untreated/contaminated water, rats, mosquitoes, contaminated food, vomit, poor sanitation). True or false was chosen. Variables were recoded to correct (1) and incorrect (0), and summed for a final score (0-7, 7=highest knowledge)
| score on a scale | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Change in H. Pylori Knowledge Between Baseline and 6-months | 1.03 ± 2 | 2.56 ± 2.5 |
Participants completed the PROMIS Global Physical Health Scale, which assessed participants' physical health, at baseline and 6-month follow-up. Four questions assessed global physical health. Three questions were administered using five-category response scales, and one item used a response scale of 0-10 that was recoded to five categories. Responses are recoded into t-scores, which rescales the raw sum score into a standardized score from 0-100, with a mean of 50 and a standard deviation of 10. Higher scores indicate more of the concept being measured.
| T-score | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Change in PROMIS Global Physical Health T-Score Between Baseline and 6-months | -1.1 ± 2.71 | 1.27 ± 8.27 |
Participants completed the PROMIS Global Mental Health Scale, which assessed participants' mental health, at baseline and 6-month follow-up. Four questions assessed global mental health, and all were administered using five-category response scales. Responses are recoded into t-scores, which rescales the raw sum score into a standardized score from 0-100, with a mean of 50 and a standard deviation of 10. Higher scores indicate more of the concept being measured.
| T-score | Health Systems-level Intervention | CHW-led Patient Navigation Program |
|---|---|---|
| Change in PROMIS Global Mental Health T-Score Between Baseline and 6-months | 0.69 ± 6.84 | 3.13 ± 6.07 |
Collected over 6 Months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Health Systems-level Intervention | 0/67 (0%) | 0/67 (0%) | 0/67 (0%) |
| CHW-led Patient Navigation Program | 0/68 (0%) | 0/68 (0%) | 0/68 (0%) |
| Age, Continuous(years) | Health Systems-level Intervention | CHW-led Patient Navigation Program | Total |
|---|---|---|---|
| Mean | 44 (23 to 81) | 42 (25 to 69) | 43.5 (23 to 81) |
| Sex: Female, Male(Participants) | Health Systems-level Intervention | CHW-led Patient Navigation Program | Total |
|---|---|---|---|
| Female | 36 | 34 | 70 |
| Male | 31 | 30 | 61 |
| Ethnicity (NIH/OMB)(Participants) | Health Systems-level Intervention | CHW-led Patient Navigation Program | Total |
|---|---|---|---|
| Hispanic or Latino | 0 | 0 | 0 |
| Not Hispanic or Latino | 67 | 64 | 131 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Health Systems-level Intervention | CHW-led Patient Navigation Program | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 67 | 64 | 131 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 0 | 0 | 0 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(participants) | Health Systems-level Intervention | CHW-led Patient Navigation Program | Total |
|---|---|---|---|
| United States | 67 | 64 | 131 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.